SCHEMBL7646302

SCHEMBL7646302

Oc1ccc2c(c1)C[C]NC2

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.37
DRD4 P21917 4/20 0.37
DRD1 P21728 5/20 0.36
DRD3 P35462 6/20 0.35
DRD5 P21918 4/20 0.35
OPRK1 P41145 1/20 0.34
PBRM1 Q86U86 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CA2 P00918 2/20 0.33
CA1 P00915 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B10 Q99714 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL354223 0.92 DRD2 (0.37) DRD2DRD4DRD1DRD3DRD5
SCHEMBL37705 0.72 PNMT (0.39) HSD17B10
SCHEMBL30015222 0.72 DRD2 (0.46) DRD2DRD4DRD1DRD3DRD5
SCHEMBL329946 0.72 DRD2 (0.46) DRD2DRD4DRD1DRD3DRD5
Hydrochloric Acid SCHEMBL3772707 0.70 DRD2 (0.44) DRD2DRD4DRD1DRD3DRD5
Bromide SCHEMBL383952 0.70 DRD2 (0.44) DRD2DRD4DRD1DRD3DRD5
SCHEMBL29514775 0.65 DRD2 (0.62) DRD2DRD4DRD1DRD3DRD5
SCHEMBL1017452 0.65 DRD2 (0.62) DRD2DRD4DRD1DRD3DRD5
SCHEMBL7651931 0.64 CHRNB2 (0.37) DRD2DRD4DRD3OPRK1ESR1
Bromide SCHEMBL587893 0.64 DRD2 (0.61) DRD2DRD4DRD1DRD3DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6482921-B1 Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use ESSENTIAL THERAPEUTICS, INC. 2002-11-19 US claimed
WO-2000044335-A2 URIDYL PEPTIDE ANTIBIOTIC (UPA) DERIVATIVES, THEIR SYNTHESIS AND USE MICROCIDE PHARMACEUTICALS, INC. (US) 2000-08-03 WO claimed
EP-0517345-B1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO CO (JP) 1995-07-19 EP claimed
EP-0317292-B1 NEW ANTIBIOTICS OF THE MUREIDOMYCIN GROUP, THEIR PREPARATION, AND THEIR THERAPEUTIC USE Sankyo Company Limited (JP) 1993-04-07 EP claimed
EP-0517345-A1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO COMPANY LIMITED (JP) 1992-12-09 EP claimed
US-5041423-A Antibiotics of the mureidomycin group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1991-08-20 US claimed
EP-0317292-A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use Sankyo Company Limited (JP) 1989-05-24 EP claimed
JP-1230568-A None JP disclosed
EP-0517345-B1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO CO (JP) 1995-07-19 EP disclosed
EP-0317292-B1 NEW ANTIBIOTICS OF THE MUREIDOMYCIN GROUP, THEIR PREPARATION, AND THEIR THERAPEUTIC USE Sankyo Company Limited (JP) 1993-04-07 EP disclosed
EP-0517345-A1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO COMPANY LIMITED (JP) 1992-12-09 EP disclosed
US-5041423-A Antibiotics of the mureidomycin group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1991-08-20 US disclosed
US-5041423-A Antibiotics of the mureidomycin group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1991-08-20 US disclosed
JP-H01230568-A MUREIDOMYCIN DERIVATIVE SANKYO CO LTD 1989-09-14 JP disclosed
EP-0317292-A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use Sankyo Company Limited (JP) 1989-05-24 EP disclosed
EP-0317292-A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use Sankyo Company Limited (JP) 1989-05-24 EP disclosed